Page last updated: 2024-08-24

irinotecan and Hypocalcemia

irinotecan has been researched along with Hypocalcemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, W; Li, M; Sun, X; Wang, Z; Wei, H; Zou, X1
Chung, KY; Flombaum, C; Saltz, L; Schrag, D1

Reviews

1 review(s) available for irinotecan and Hypocalcemia

ArticleYear
Cetuximab therapy and symptomatic hypomagnesemia.
    Journal of the National Cancer Institute, 2005, Aug-17, Volume: 97, Issue:16

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Colorectal Neoplasms; ErbB Receptors; Fatigue; Humans; Hypocalcemia; Incidence; Irinotecan; Magnesium; Magnesium Deficiency; Male; Severity of Illness Index

2005

Other Studies

1 other study(ies) available for irinotecan and Hypocalcemia

ArticleYear
Metastatic colorectal cancer and severe hypocalcemia following irinotecan administration in a patient with X-linked agammaglobulinemia: a case report.
    BMC medical genetics, 2019, 09-12, Volume: 20, Issue:1

    Topics: Adult; Agammaglobulinaemia Tyrosine Kinase; Agammaglobulinemia; Asian People; ATP-Binding Cassette Transporters; B-Lymphocytes; Calcium Channels, L-Type; Capecitabine; Colorectal Neoplasms; Complement C6; Drug Monitoring; Drug Therapy; Exome Sequencing; Genetic Association Studies; Genetic Diseases, X-Linked; Genetic Predisposition to Disease; Humans; Hypocalcemia; Immunoglobulins; Irinotecan; Male; Mutation; Oxaliplatin; PAX3 Transcription Factor; Young Adult

2019